Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

Authors: Daria N Podlekareva, Joanne Reekie, Amanda Mocroft, Marcelo Losso, Aza G Rakhmanova, Elzbieta Bakowska, Igor A Karpov, Jeffrey V Lazarus, Jose Gatell, Jens D Lundgren, Ole Kirk, for the EuroSIDA study in EuroCoord

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

State-of-the-art care involving the utilisation of multiple health care interventions is the basis for an optimal long-term clinical prognosis for HIV-patients. We evaluated health care for HIV patients based on four key indicators.

Methods

Four indicators of health care were assessed: Compliance with current guidelines on initiation of: 1) combination antiretroviral therapy (cART); 2) chemoprophylaxis; 3) frequency of laboratory monitoring; and 4) virological response to cART (proportion of patients with HIV-RNA < 500copies/ml for >90% of time on cART).

Results

7097 EuroSIDA patients were included from Northern (n = 923), Southern (n = 1059), West Central (n = 1290) East Central (n = 1366), Eastern (n = 1964) Europe, and Argentina (n = 495). Patients in Eastern Europe with a CD4 < 200cells/mm3 were less likely to initiate cART and Pneumocystis jiroveci-chemoprophylaxis compared to patients from all other regions, and less frequently had a laboratory assessment of their disease status. The proportion of patients with virological response was highest in Northern, 89% vs. 84%, 78%, 78%, 61%, 55% in West Central, Southern, East Central Europe, Argentina and Eastern Europe, respectively (p < 0.0001). Compared to Northern, patients from other regions had significantly lower odds of virological response; the difference was most pronounced for Eastern Europe and Argentina (adjusted OR 0.16 [95%CI 0.11-0.23, p < 0.0001]; 0.20[0.14-0.28, p < 0.0001] respectively).

Conclusions

This assessment of HIV health care utilization revealed pronounced regional differences in adherence to guidelines and can help to identify gaps and direct target interventions. It may serve as a tool for the assessment and benchmarking of the clinical management of HIV patients in any setting worldwide.
Appendix
Available only for authorised users
Literature
2.
go back to reference Gazzard BG, British HIV: Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008, 9 (8): 563-608. 10.1111/j.1468-1293.2008.00636.x.CrossRefPubMed Gazzard BG, British HIV: Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008, 9 (8): 563-608. 10.1111/j.1468-1293.2008.00636.x.CrossRefPubMed
6.
go back to reference Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000, 342 (13): 921-929.CrossRef Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000, 342 (13): 921-929.CrossRef
7.
go back to reference Horberg MA, Aberg JA, Cheever LW, Renner P, Kaleba EO, Asch SM: Development of National and Multiagency HIV Care Quality Measures. Clin Infect Dis. 2010, 51 (6): 732-738. 10.1086/655893. September 15CrossRefPubMed Horberg MA, Aberg JA, Cheever LW, Renner P, Kaleba EO, Asch SM: Development of National and Multiagency HIV Care Quality Measures. Clin Infect Dis. 2010, 51 (6): 732-738. 10.1086/655893. September 15CrossRefPubMed
8.
go back to reference Samaranayake A, Chen MY, McNeil J, Read TRH, Hocking JS, Bradshaw CS, et al: Definitions of antiretroviral treatment failure for measuring quality outcomes. HIV Med. 2010, 11 (7): 427-431.PubMed Samaranayake A, Chen MY, McNeil J, Read TRH, Hocking JS, Bradshaw CS, et al: Definitions of antiretroviral treatment failure for measuring quality outcomes. HIV Med. 2010, 11 (7): 427-431.PubMed
10.
go back to reference Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA, et al: Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003, 362 (9377): 22-29. 10.1016/S0140-6736(03)13802-0. July 5CrossRefPubMed Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA, et al: Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003, 362 (9377): 22-29. 10.1016/S0140-6736(03)13802-0. July 5CrossRefPubMed
11.
go back to reference Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, et al: The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe–a review of published results. Cent Eur J Public Health. 2008, 16 (3): 99-105. SeptemberPubMed Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, et al: The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe–a review of published results. Cent Eur J Public Health. 2008, 16 (3): 99-105. SeptemberPubMed
12.
go back to reference Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992, 18 (41(RR-17)): 1-19. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992, 18 (41(RR-17)): 1-19.
13.
go back to reference Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H: Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009, 58 (RR-4): 1-207. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H: Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009, 58 (RR-4): 1-207.
14.
go back to reference Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van LJ, et al: History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV Med. 2010, 11 (7): 469-478. AugustPubMed Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van LJ, et al: History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV Med. 2010, 11 (7): 469-478. AugustPubMed
15.
go back to reference Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, et al: Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study. PLoS One. 2012, 7 (7): e41673-10.1371/journal.pone.0041673. July 23CrossRefPubMedPubMedCentral Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, et al: Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study. PLoS One. 2012, 7 (7): e41673-10.1371/journal.pone.0041673. July 23CrossRefPubMedPubMedCentral
16.
go back to reference Kiefe CI, Weissman NW, Allison JJ, Farmer R, Weaver M, Williams OD: Identifying achievable benchmarks of care: concepts and methodology. Int J Qual Health Care. 1998, 10 (5): 443-447. 10.1093/intqhc/10.5.443. OctoberCrossRefPubMed Kiefe CI, Weissman NW, Allison JJ, Farmer R, Weaver M, Williams OD: Identifying achievable benchmarks of care: concepts and methodology. Int J Qual Health Care. 1998, 10 (5): 443-447. 10.1093/intqhc/10.5.443. OctoberCrossRefPubMed
17.
go back to reference Crabtree-Ramirez B, Caro-Vega Y, Shepherd BE, Wehbe F, Cesar C, Cortes C, et al: Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One. 2011, 6 (5): e20272-10.1371/journal.pone.0020272.CrossRefPubMedPubMedCentral Crabtree-Ramirez B, Caro-Vega Y, Shepherd BE, Wehbe F, Cesar C, Cortes C, et al: Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One. 2011, 6 (5): e20272-10.1371/journal.pone.0020272.CrossRefPubMedPubMedCentral
18.
go back to reference Hamers FF, Downs AM: HIV in central and eastern Europe. Lancet. 2003, 361: 1035-1044. 10.1016/S0140-6736(03)12831-0.CrossRefPubMed Hamers FF, Downs AM: HIV in central and eastern Europe. Lancet. 2003, 361: 1035-1044. 10.1016/S0140-6736(03)12831-0.CrossRefPubMed
19.
go back to reference Donoghoe MC, Bollerup AR, Lazarus JV, Nielsen S, Matic S: Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002–2004. Int J Drug Policy. 2007, 18 (4): 271-280. 10.1016/j.drugpo.2007.02.010. AugustCrossRefPubMed Donoghoe MC, Bollerup AR, Lazarus JV, Nielsen S, Matic S: Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002–2004. Int J Drug Policy. 2007, 18 (4): 271-280. 10.1016/j.drugpo.2007.02.010. AugustCrossRefPubMed
20.
go back to reference Cohen D: HIV/AIDS is spreading fastest in eastern Europe and Asia. BMJ. 2004, 329 (7457): 67-July 10PubMed Cohen D: HIV/AIDS is spreading fastest in eastern Europe and Asia. BMJ. 2004, 329 (7457): 67-July 10PubMed
Metadata
Title
Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study
Authors
Daria N Podlekareva
Joanne Reekie
Amanda Mocroft
Marcelo Losso
Aza G Rakhmanova
Elzbieta Bakowska
Igor A Karpov
Jeffrey V Lazarus
Jose Gatell
Jens D Lundgren
Ole Kirk
for the EuroSIDA study in EuroCoord
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-229

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.